News / USA

US Developing Radiation Sickness Drug

Ex-Rad could be used before or after exposure

Evacuees are screened for radiation contamination at a testing center Tuesday, March 15, 2011, in Koriyama city, Fukushima Prefecture, northern Japan, four days after a massive earthquake and tsunami struck the country's north east coast.
Evacuees are screened for radiation contamination at a testing center Tuesday, March 15, 2011, in Koriyama city, Fukushima Prefecture, northern Japan, four days after a massive earthquake and tsunami struck the country's north east coast.

Multimedia

Vidushi Sinha

The serious radiation leaks at Japan's damaged Fukushima-Daiichi nuclear power plant have reawakened public fears about radiation sickness. But what if there were a drug that could not only protect people from dangerous levels of radiation exposure but also heal those actually exposed to damaging nuclear radiation?

Researchers say they are developing such a drug - one that can both prevent and repair human cell damage from all types of radiation exposure.

Such a healing medication has the potential to lessen panic and fear generated by catastrophic reactor accidents. Plant workers trying to make repairs near a crippled reactor's radioactive core might be less fearful if they could take a pill to repair their own radiation-damaged cells.

Ramesh Kumar, the CEO of a U.S. drug research firm called Onconova, says his company has just such a wonder drug in the works.

The company has been collaborating on the drug, called Ex-Rad, with scientists at a U.S. Defense Department research laboratory. Kumar says early animal trials have been promising.

“Ex-Rad is a drug which is effective in saving a cell damaged by radiation," he says, "and we have found that it can be given in advance of exposure to radiation up to a day ahead or it can be given up to a day after the exposure to radiation.”

There are existing antidotes for radiation exposure which have been approved by the federal Food and Drug Administration (FDA). Potassium iodide, also known as the radiation pill, prevents the body's absorption of the radioactive iodine present in reactor emissions. For a person poisoned by radioactive isotopes such as plutonium and cesium - types of radiation being released from the Fukushima reactors - FDA-approved drugs such as Prussian Blue capsules can quickly flush radioactive elements from the body. However, right now there are no drugs specifically for treating radiation sickness itself.

The Armed Forces Radiobiology Research Institute has been leading the Pentagon's quest for a more effective antidote to radiation sickness, which has a wide range of symptoms.

“The symptoms of acute radiation sickness will be just exactly like a terrible flu," says Col. Andrew Huff, a spokesman for the research institute. "The person would have headache. They would feel very tired. They would have little bit of fever. They might have some vomiting at higher doses all of this and more but at survivable doses it would come on within 24 to 36 hours."

According to Huff, the body loses its platelet and neutrophil supply and people can eventually die of bleeding. He says the Pentagon's search for radiation sickness treatments is intensifying.

“The other more vexing problem, the one that we really have to worry about for larger numbers of people - if there were nuclear terrorism - is how much external ionizing penetrating radiation a person would get after a nuclear detonation."

To combat such a crisis - or to treat people exposed to radiation from a damaged nuclear reactor - the Department of Defense and Onconova have collaborated on the development of Ex-Rad.

“FDA has devised a development path for drugs like Ex-Rad which involves clinical trials, animal studies, and additional controls for manufacturing and we are in the process of completing these studies," says Kumar, whose company is developing Ex-Rad. "We started this process in 2008 under and FDA's Investigational New Drug Exemption. We have carried out clinical studies in human subjects for safety and we are in the process of continuing to do animal efficacy studies so once all of these studies are completed we can get an approval for specific indication. It could be prophylactic use before - or after - exposure.  It could be injectable or oral.”

Kumar says Ex-Rad won't be available for at least another two or three years. In the meantime, government officials warn the public to be cautious about the growing number of claims being made on the Internet for anti-radiation drugs that purport to be miracle cures.

You May Like

Video On the Scene: In Gaza, Darkness Brings Dread and Death

Palestinians fear nighttime raids, many feel abandoned by outside world, VOA's Scott Bobb reports More

African Small Farmers Could Be Key to Ending Food Insecurity

Experts say providing access to microloans, crop insurance, better storage facilities, irrigation, road systems and market information could enable greater production More

University of Michigan Wins Solar Car Race

Squad guided its student-designed solar-powered vehicle to fifth consecutive time victory in eight-day bi-annual American Solar Challenge More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Gazans in Shelled School Sought Shelteri
X
Scott Bobb
July 30, 2014 8:16 PM
Israel's air and ground assault against Hamas-led fighters in Gaza has forced many Palestinians to flee their homes, seeking safety. But safe places are hard to find, as VOA’s Scott Bobb reports from Jabaliya.
Video

Video Gazans in Shelled School Sought Shelter

Israel's air and ground assault against Hamas-led fighters in Gaza has forced many Palestinians to flee their homes, seeking safety. But safe places are hard to find, as VOA’s Scott Bobb reports from Jabaliya.
Video

Video Rapid Spread of Ebola in West Africa Prompts Global Alert

Across West Africa, health officials are struggling to keep up with what the World Health Organization describes as the worst ebola outbreak on record. The virus has killed hundreds of people this year. U.S. President Barack Obama and other world leaders are watching the developments closely as they weigh what actions, if any, are needed to help contain the disease.
Video

Video Michelle Obama: Young Africans Need to Embrace Women's Rights

U.S. first lady Michelle Obama urged some of Africa's best and brightest to advocate for women's rights in their home countries. As VOA's Pam Dockins explains, Obama spoke to some 500 participants of the Young African Leaders Initiative, a six-week U.S.-based training and development program.
Video

Video Immigrant Influx on Texas Border Heats Up Political Debate

Immigrants from Central America continue to cross the U.S.-Mexico border in south Texas, seeking asylum in the United States, as officials grapple with ways to deal with the problem and provide shelter for thousands of minors among the illegal border crossers. As VOA's Greg Flakus reports from Houston, the issue is complicated by internal U.S. politics and U.S. relations with the troubled nations that immigrants are fleeing.
Video

Video Study: Latino Students Most Segregated in California

Even though legal school segregation ended in the United States 60 years ago, one study finds segregation still occurs in the U.S. based on income and race. The University of California Los Angeles Civil Rights Project finds that students in California are more segregated by race than ever before, especially Latinos. Elizabeth Lee reports for VOA from Los Angeles.
Video

Video Vietnamese Staging Chinese Product Boycott After Oil Rig Spat

China recently pulled an oil rig from an area of the disputed South China Sea that Vietnam also claims. Despite the action, the incident has had a lingering effect on consumers in Vietnam. VOA's Reasey Poch reports from Hanoi on an effort to boycott Chinese products.
Video

Video A Summer Camp for All the World

VIDEO: During workshops and social gatherings, the Global Youth Village summer camp encourages young people to cooperate and embrace their differences, while learning to communicate with people from other countries. VOA's Deborah Block has more.
Video

Video From Cantankerous Warlock to Incorruptible Priest, 'Harry Potter' Actor Embraces Diverse Roles

He’s perhaps best known as Mad Eye Moody, the whimsical wizard in the Harry Potter franchise. But character actor Brendan Gleeson's resume includes dozens of films, and he embraces all the characters he inhabits with equal passion. In an interview with VOA’s Penelope Poulou, Gleeson discussed his new drama "Calvary" and his secret to success.

AppleAndroid